These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18344111)

  • 1. A case of 5-fluorouracil-induced peripheral neuropathy.
    Werbrouck BF; Pauwels WJ; De Bleecker JL
    Clin Toxicol (Phila); 2008 Mar; 46(3):264-6. PubMed ID: 18344111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
    van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
    Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic 5-fluorouracil-induced sinus bradycardia.
    Lee AD; McKay MJ
    Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
    Maurer U; Härle M; Jungius KP
    Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials.
    Lukaschek J; Nufer M; Maurer D; Asanger M; Honegger H; Widmer L; Malet-Martino M; Legay R; Martino R
    J Clin Oncol; 2004 Dec; 22(24):5022-5. PubMed ID: 15611524
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case report of a patient with hand-foot syndrome induced by bolus 5-fluorouracil therapy].
    Matsuyama T; Uetake H; Aoyagi H; Kobayashi H; Ishikawa T; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2147-9. PubMed ID: 19106552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute proctocolitis with commencement of neoadjuvant chemoradiation for rectal cancer.
    Kendal WS; Jonker D; Stern H; Moyana T
    Am J Clin Oncol; 2006 Oct; 29(5):534-5. PubMed ID: 17023795
    [No Abstract]   [Full Text] [Related]  

  • 8. A bilateral cicatricial ectropion and bilateral upper lid shortening caused by 5-fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
    Obi EE; McDonald A; Kemp E
    Cutan Ocul Toxicol; 2011 Jun; 30(2):157-9. PubMed ID: 21077799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral neuropathy exacerbation associated with topical 5-fluorouracil.
    Saif MW; Hashmi S; Mattison L; Donovan WB; Diasio RB
    Anticancer Drugs; 2006 Oct; 17(9):1095-8. PubMed ID: 17001184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cutaneous lupus flare induced by systemic 5-fluorouracil.
    Kluger N; Bessis D; Guillot B
    J Dermatolog Treat; 2006; 17(1):51-3. PubMed ID: 16467025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolus.
    Pasetto LM; Sinigaglia G; Basso U; Cocchio S; Compostella A; Pucciarelli S; Friso ML; Rugge M; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(6B):4095-100. PubMed ID: 19192666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer.
    Mundt P; Mochmann HC; Ebhardt H; Zeitz M; Duchmann R; Pauschinger M
    Oncology; 2007; 73(3-4):270-2. PubMed ID: 18424892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical toxicity associated with 5-Fluororacil in a DPD-deficient patient with pancreatic cancer. Is ethnicity a risk factor?
    Saif MW; Seller S; Diasio RB
    JOP; 2008 Mar; 9(2):226-9. PubMed ID: 18326935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
    Wijesinghe N
    N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity.
    Milla P; Airoldi M; Weber G; Drescher A; Jaehde U; Cattel L
    Anticancer Drugs; 2009 Jun; 20(5):396-402. PubMed ID: 19287306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
    Porta C; Moroni M; Ferrari S; Nastasi G
    Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ 40 years of 5-fluorouracil--still an attractive cytostatic].
    Hofer S; Herrmann R
    Schweiz Med Wochenschr; 1998 Aug; 128(34):1253-60. PubMed ID: 9757491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.